These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1942212)

  • 21. Indirect evidence of ectopic pancreatic fascioliasis in a human.
    Lee OJ; Kim TH
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1631-3. PubMed ID: 16928233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phagocytic activity of neutrophils in human fasciolosis before and after treatment.
    Osman MM; Rashwan E; Farag HF
    J Egypt Soc Parasitol; 1995 Aug; 25(2):321-7. PubMed ID: 7665930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infection with Fasciola hepatica.
    Aksoy DY; Kerimoglu U; Oto A; Erguven S; Arslan S; Unal S; Batman F; Bayraktar Y
    Clin Microbiol Infect; 2005 Nov; 11(11):859-61. PubMed ID: 16216098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hepatic fascioliasis resistant to bithionol treatment but responsive to triclabendazole].
    Medrano F; de Tomás E; Barba MA; Alamillo A; Ferreras P
    Enferm Infecc Microbiol Clin; 1999; 17(7):371-2. PubMed ID: 10535200
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of nitazoxanide treatment following triclabendazole failure in an outbreak of human fascioliasis in Upper Egypt.
    Ramadan HK; Hassan WA; Elossily NA; Ahmad AA; Mohamed AA; Abd-Elkader AS; Abdelsalam EMN; Khojah HMJ
    PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007779. PubMed ID: 31553716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on human fascioliasis in Egypt. 2. Serum iron and copper in chronic fascioliasis.
    Salem A; Osman M; Kandil M; Abaza M; Elewa S
    J Egypt Soc Parasitol; 1993 Aug; 23(2):357-64. PubMed ID: 8376852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fascioliasis: case reports and review.
    Price TA; Tuazon CU; Simon GL
    Clin Infect Dis; 1993 Sep; 17(3):426-30. PubMed ID: 8218685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human fascioliasis: clinical features and diagnostic difficulties in Egyptian children.
    el-Shabrawi M; el-Karaksy H; Okasha S; el-Hennawy A
    J Trop Pediatr; 1997 Jun; 43(3):162-6. PubMed ID: 9231637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical trial of Mirazid in treatment of human fascioliasis, Ezbet El-Bakly (Tamyia Center) Al-Fayoum Governorate.
    Abo-Madyan AA; Morsy TA; Motawea SM; Morsy AT
    J Egypt Soc Parasitol; 2004 Dec; 34(3):807-18. PubMed ID: 15587309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value of bithionol in the treatment of hepatic fascioliasis in children].
    Abreu F; Aidos A; Rebelo I; Lacerda C; Palminha JM
    Arch Pediatr; 1996 Feb; 3(2):189-91. PubMed ID: 8785549
    [No Abstract]   [Full Text] [Related]  

  • 31. Alpha esterase enzyme in liver of rabbits infected with Fasciola gigantica and treated with bithionol.
    Abou Basha LM; El-Magdoub AA; Hosny KM; Michael AI; El Toukhy MA; Ebied SM; Farag HF; El Zoughby SM
    J Egypt Soc Parasitol; 1982 Dec; 12(2):489-94. PubMed ID: 7153561
    [No Abstract]   [Full Text] [Related]  

  • 32. Computed tomography findings of hepatic lesions in human fascioliasis: report of two cases.
    Takeyama N; Okumura N; Sakai Y; Kamma O; Shima Y; Endo K; Hayakawa T
    Am J Gastroenterol; 1986 Nov; 81(11):1078-81. PubMed ID: 3776958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bitifen in fascioliasis and paramphistomiasis].
    Mereminskiĭ AI; Gluzman IIa
    Veterinariia; 1975 Jul; (7):57-8. PubMed ID: 1216598
    [No Abstract]   [Full Text] [Related]  

  • 34. Preliminary study of therapeutic efficacy of a new fasciolicidal drug derived from Commiphora molmol (myrrh).
    Massoud A; El Sisi S; Salama O; Massoud A
    Am J Trop Med Hyg; 2001 Aug; 65(2):96-9. PubMed ID: 11508399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Echography in the diagnosis of fascioliasis].
    Ruiz Rebollo ML; Basagoiti Uriarte ML; Bustamante Schneider F; Marce Landeta L; Del Castillo Uría J; Delgado Fontaneda E
    Rev Esp Enferm Dig; 1991 Apr; 79(4):297-8. PubMed ID: 2054219
    [No Abstract]   [Full Text] [Related]  

  • 36. Triclabendazole in the treatment of human fascioliasis: a community-based study.
    el-Morshedy H; Farghaly A; Sharaf S; Abou-Basha L; Barakat R
    East Mediterr Health J; 1999 Sep; 5(5):888-94. PubMed ID: 10983527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obstruction of common bile duct caused by liver fluke--Fasciola hepatica.
    Kiladze M; Chipashvili L; Abuladze D; Jatchvliani D
    Sb Lek; 2000; 101(3):255-9. PubMed ID: 11220154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fasciola hepatica infestation. Biopathology and new diagnostic and therapeutic aspects].
    de Górgolas M; Torres R; Verdejo C; Garay J; Robledo A; Ponte MC; Fernández Guerrero ML
    Enferm Infecc Microbiol Clin; 1992 Nov; 10(9):514-9. PubMed ID: 1489790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of two doses of triclabendazole in treatment of patients with combined schistosomiasis and fascioliasis.
    Osman MM; Shehab AY; Zaki A; Farag HF
    East Mediterr Health J; 2011 Apr; 17(4):266-70. PubMed ID: 22259882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sonographic findings of hepatic lesions in human fascioliasis.
    Cosme A; Ojeda E; Poch M; Bujanda L; Castiella A; Fernández J
    J Clin Ultrasound; 2003 Sep; 31(7):358-63. PubMed ID: 12923880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.